輸入代號或公司名稱後按 Enter
6499

益安

-1.20 (-1.68%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
70.10194成交張數本益比5.52股價淨值比0.00%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q2-1.28-5.97-1.25-117.0%-9.64%-47.87%
2026Q1-1.26-6.59-1.22-106.6%-8.60%-45.30%
2025Q4-1.48-7.24-1.37-119.4%-10.35%-44.60%
2025Q3-1.95-7.99-1.75-189.4%-15.35%-51.14%
2025Q2-1.91-8.02-1.78-161.4%-14.56%-49.47%
2025Q1-1.91-8.39-1.78-174.7%-12.43%-45.08%
2024Q4-2.23-8.63-2.09-270.0%-12.89%-41.95%
2024Q3-1.97-8.59-1.84-176.0%-10.12%-37.65%
2024Q2-2.28-8.69-2.12-334.4%-10.47%-34.96%
2024Q1-2.14-13.20-2.00-423.9%-8.97%-44.62%
2023Q4-2.19-12.92-2.05-368.8%-8.43%-40.71%
2023Q3-2.08-12.71-1.94-423.7%-7.38%-37.44%
2023Q2-6.79-11.96-6.33-1222.9%-20.76%-33.80%
2023Q1-1.86-358.3%-7.24-1.74-400.8%-4.98%-17.91%
2022Q4-1.98-4.65-1.85-500.1%-5.00%-11.23%
2022Q3-1.33-3.83-1.25-300.2%-3.25%-8.87%
2022Q2-2.06-107.9%-4.43-1.92-653.3%-4.77%-9.81%
2022Q10.7223.860.6735.3%1.62%71.63%
2021Q4-1.1622.36-1.07-1074.8%-2.55%67.31%
2021Q3-1.9323.37-1.79-1833.2%-4.10%72.21%
2021Q226.2324.6124.366347.3%74.77%72.03%
2021Q1-0.78-2.29-0.73-46.6%-3.55%-10.61%
2020Q4-0.15-2.07-0.13-6.0%-0.70%-9.52%
2020Q3-0.68-2.81-0.64-41.3%-3.50%-13.72%
2020Q2-0.67-2.88-0.62-44.6%-3.24%-13.44%
2020Q1-0.57-2.81-0.54-39.1%-2.70%-12.50%
2019Q4-0.89-2.82-0.83-68.4%-4.11%-14.38%
2019Q3-0.75-2.44-0.70-55.7%-3.34%-11.94%
2019Q2-0.60-2.29-0.56-50.1%-2.56%-10.44%
2019Q1-0.58-112.6%-2.01-0.53-55.7%-2.71%-8.53%
2018Q4-0.513.20-0.43-52.9%-2.59%17.21%
2018Q3-0.602.75-0.48-76.6%-2.89%14.46%
2018Q2-0.322.65-0.26-41.4%-1.50%13.55%
2018Q14.632.233.7379.7%24.39%11.12%
2017Q4-0.96-3.10-0.77-166.5%-5.58%-16.86%
2017Q3-0.70-3.04-0.55-201.3%-3.81%-15.63%
2017Q2-0.75-0.60-110.6%-3.98%
2017Q1-0.70-0.55-150.3%-3.53%
2016Q4-0.90-0.70-4.31%
2016Q3-0.71-0.54